← Back to ARTL

Artelo Biosciences, Inc. - Common Stock financial statements

Annual and standalone quarterly facts filed by the company with the SEC. Monetary values are shown in USD millions; per-share values use USD.

Filed statements

USD; millions except EPSJun 2026Filed 12/08/2026Mar 2026Filed 14/05/2026Sep 2025Filed 12/11/2025Jun 2025Filed 12/08/2026Mar 2025Filed 14/05/2026Sep 2024Filed 12/11/2025Jun 2024Filed 12/11/2025Mar 2024Filed 12/11/2025
−$2.4−$3−$3.1−$3.2−$2.4−$1.1−$2.4−$2.5
−$0.89−$4.00−$3.97−$16.86−$12.55−$2.10−$4.52−$4.66
2.70.70.80.20.20.50.50.5

Trend

Net income

Source: SEC EDGAR Company Facts. Values are normalized from issuer-filed US GAAP or IFRS XBRL facts. Missing cells stay missing; cumulative interim cash flows are not converted into estimated quarters.